Home » Topics » BioWorld Science

BioWorld Science
RSS

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

June 29, 2018

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

June 29, 2018

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

June 29, 2018

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

June 29, 2018

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

June 29, 2018

Inovio reports phase I results for INO-4700 in MERS

June 29, 2018

Kangpu initiates phase I study of KPG-121 for metastatic CRPC

June 29, 2018

FDA clears of IND application for OC-01 as treatment of dry eye disease

June 29, 2018

GBM cells spread their message beyond death

June 29, 2018

The locus of alcohol's reward

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...